When the hope goes: Talking with patients after withdrawal from cancer clinical trials
Cancer clinical trials remain underutilized by patients as a means of acquiring experimental drugs, tests and/or procedures that they otherwise might not be able to obtain. Connie Ulrich spoke to Healio about why people withdraw from clinical trials.
The Relationship between Health and Place: Expanding Use of Place-Based Disadvantage Indices Beyond COVID-19
While disadvantage indices are increasingly recognized as a valuable tool to help promote health and prioritize equity, future use of these tools must include investments in data infrastructure, community partnerships, and further evaluation. Harald Schmidt provides insight.